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Genetic factors in animal models
of intestinal inflammation
R BALFOUR SARTOR MD
CLINICAL INVESTIGATORS HAVEcompellingly documented a ge-
netic component in ulcerative colitis
and Crohn’s disease (1). There is an in-
creased incidence of inflammatory
bowel disease (IBD) in family members,
a predilection for these disorders in cer-
tain genetically defined ethnic groups,
higher concordance of disease in
monozygotic versus dizygotic twins and
familial patterns of clinical pheno-
types. However, human genetic re-
search has not yet provided clinically
useful disease susceptibility markers
nor an understanding of the immuno-
pathogenesis of IBD.
The critical importance of host ge-
netic susceptibility in determining
chronicity, aggressiveness and compli-
cations of intestinal inflammation is
clearly demonstrated by studies in in-
bred rodents, transgenic rats, gene
knockout mice and spontaneous mu-
tants (Table 1). This report summarizes
evidence of genetic control of intesti-
nal and extraintestinal inflammation
in these models, briefly outlines possi-
ble immunological mechanisms of en-
hanced genetic susceptibility and
discusses the relevance of these obser-




The cotton-top tamarin and the
recently developed C3H/HeJ Bir sub-
strain mouse develop chronic, sponta-
neously relapsing colitis. The mecha-
nisms of intestinal inflammation in
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these animals are unknown, but pre-
sumably are the result of a spontaneous
genetic mutation because closely re-
lated strains do not develop colitis and
aggressive searches have not identified
environmental microbial pathogens.
At least 11 different species and hy-
brids of tamarins, a group of New
World monkeys, spontaneously de-
velop mild chronic colitis with mucosal
atrophy (2). Cotton-top tamarins are
unique in that they exhibit acute re-
lapsing colitis complicated by adeno-
carcinoma of the colon (2-4). Captive
cotton-top tamarins frequently de-
velop a wasting syndrome character-
ized by weight loss, anorexia and diar-
rhea. An age-related chronic colitis is
almost universally present by two years
of age. Underlying chronic colitis is
relatively mild, characterized by a
thickened mucosa with hyperplastic,
elongated crypts, pseudopolyps and
mild mononuclear cell infiltration of
the lamina propria. At any given time
approximately one-half to two-thirds
of marmosets have histological evi-
dence of acute colonic inflammation,
with neutrophilic infiltration, crypt ab-
scesses and goblet cell depletion, but
rarely have ulceration. Adenocarcinoma
that complicates chronic colitis is not
preceded by epithelial cell dysplasia or
adenomatous polyps. Some tamarins
develop chronic periportal inflamma-
tion with fibrosis.
The mechanism(s) of intestinal in-
flammation in cotton-top tamarins re-
mains unclear. The inflammatory
mediator profile of increased inter-
leukin (IL)-1 and eicosanoids is charac-
teristic of intestinal inflammation, and
the colitis responds to sulfasalazine and
a 5-lipoxygenase inhibitor (5). These
marmosets share several biochemical
and immunological alterations with ul-
cerative colitis patients. They have a
selective reduction in mucus glycopro-
tein fraction IV which does not corre-
late with inflammatory activity (6). In
addition their serum contains antineu-
trophil cytoplasmic autoantibodies
which react with human, but not mar-
moset, neutrophils (7), and slightly in-
creased concentrations of serum
antibodies which stimulate cell-
mediated cytotoxicity to colonic
epithelial cell-associated components
(8). However, the precise genetic al-
teration that predisposes these marmo-





Birkenmeier and colleagues (9)
have recently described a heritable
form of murine colitis. It had become
apparent that sporadic diarrhea and
perianal ulceration were frequent in in-
dividual members of the Jackson Labo-
ratory C3H/HeJ mouse breeding colony
but that no microbial pathogens were
demonstrable. Selective breeding of
mice that developed diarrhea resulted
in a pedigree of mice in which there is a
50% incidence of spontaneous colitis.
Colitis is more frequent in males (67%
incidence) than females (31% inci-
dence) and exhibits a seasonal varia-
tion (occurring more often in winter
than summer). Inflammation follows a
biphasic time course with onset around
the time of weaning (three to five
weeks of age), spontaneous resolution
in most mice and a less predictable
chronic phase. Clinical manifestations
include occasional diarrhea, fecal
blood (not grossly apparent) and peri-
anal ulceration. Inflammation is most
frequently found near the ileocecal
valve but can involve the entire colon.
Histological findings include focal lin-
ear ulcers and a mixed mononuclear
and neutrophilic infiltration. Ex-
traintestinal manifestations have not
been described.
Attempts to identify the presumed
spontaneous genetic mutation are in
progress. Like the parent C3H/HeJ
strain, monocytes from mice with spon-
rats consanguins, des rats transgéniques et des mutants spontanés. Des rats Lewis
consanguins, exposés à des polymères de la paroi cellulaire purifiée de bactéries, à
l’indométhacine ou à des bactéries du grêle, ont développé une inflammation in-
testinale granulomateuse chronique avec fibrose et manifestations extra-
intestinales, alors que des rats Fisher (complexe majeur d’histocompatibilité sem-
blable à ceux des rats Lewis) et des rats Buffalo stimulés de la même façon n’ont
manifesté qu’une entérocolite à résolution spontanée, sans inflammation
chronique, fibrose, granulomes ni inflammation extra-intestinale. Des modèles
différentiels semblables d’inflammation intestinale apparaissent chez des souches
de souris consanguines exposées à de l’acide trinitrobenzènesulfonique, à Citro-
bacter freundii ou soumises à un croisement en retour avec des souris présentant un
déficit en récepteurs des cellules T. Le rôle dominant des antécédents génétiques
dans l’induction de l’inflammation de l’intestin s’appuie encore sur la présence de
colite spontanée qui se développe chez des souris mutantes, chez des tamarins,
chez des rats et de souris rendues transgéniques par une microglobuline de l’an-
tigène B27/2 des leucocytes humains avec élisions ciblées de certains gènes des
lymphocytes T et des citokines immunorégulatrices. L’identification des mécan-
ismes immunologiques de la susceptibilité génétique de l’hôte et de la base géné-
tique de la colite spontanée devrait offrir de nouveaux renseignements sur la
pathogenèse de la maladie inflammatoire de l’intestin chez l’humain.
TABLE 1
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taneous colitis are unresponsive to
lipopolysaccharide (endotoxin) (10).
Comparison of in vitro reactivity of T
lymphocytes derived from parent strain
and substrain mice with colonic cyto-
kine profiles has not been reported. In
preliminary studies, serum antibodies
from 50% of C3H/HeJ Bir mice react
with luminal bacterial extracts com-
pared with no detectable antibacterial





permit selected genes to be overex-
pressed (transgenic) or deleted (embry-
onic stem cell recombination) in
rodents. These methods have been
powerful tools to determine the in vivo
function of a targeted gene, and at
times have provided unanticipated re-
sults. Deletion of several immunoregu-
latory cytokines, including IL-2, IL-10,
transforming growth factor (TGF)-beta-
-1, Gi2 and alpha or beta T cell recep-
tor (TCR) chains, induces spontaneous
colitis (12-15). These studies show that
a single mutation of a key immunoregu-
latory cytokine, signalling molecule or
T lymphocyte protein can lead to spon-
taneous intestinal inflammation, and
that the colon is particularly suscepti-
ble to injury in immunodeficient hosts.
Overexpression of human leukocyte
antigen (HLA)-B27/2 microglobulin
(2) in transgenic rats induces a sys-
temic inflammatory syndrome in
which the first manifestation is diar-
rhea, followed by arthritis, dermatitis,
hair loss, psoriatic nail changes, epidi-
dymitis and a wasting syndrome
(16,17). Histological patterns of in-
flammation include focal chronic gas-
tritis and duodenitis, and diffuse
infiltration of the colonic lamina pro-
pria by mononuclear cells. Severely in-
flamed rats exhibit focal mucosal
ulcerations and crypt abscesses in the
colon. Cell transfer experiments dem-
onstrate that HLA-B27/2 expressing
bone marrow cells mediate the disease,
and that B27/2 protein expression
by nonimmune cells is neither neces-
sary nor sufficient to cause disease (18).
The absence of colitis, gastritis and ar-
thritis in germ-free B27/2 transgenic
rats, attenuated inflammation in spe-
cific pathogen-free rats and inhibition
by metronidazole clearly demonstrate
the importance of luminal bacteria in
initiation and perpetuation of intesti-
nal inflammation and associated ex-
traintestinal disease (19,20). The
incidence and onset of colitis and sys-
temic inflammation depend on high
copy numbers of HLA-B27/2 (17).
Compared with induced rat models of
enterocolitis (see below), the inci-
dence of intestinal inflammation in
Lewis and Fischer rats expressing
equivalent copy numbers of the
HLA-B27/2 transgene is similar, al-
though extraintestinal inflammation is
somewhat more frequent and rapid in
onset in Lewis than Fischer rats (17).
INDUCED INFLAMMATION IN
INBRED RODENT STRAINS
Differential susceptibility of inbred
rodents to intestinal and systemic in-
flammation powerfully illustrates the
key role of genetic regulation of
chronic inflammation and its compli-
cations, including fibrosis.
Inbred rat strains: The author used
three experimental models to demon-
strate that, with identical stimuli, in-
bred Lewis rats develop chronic
relapsing enterocolitis with extraintes-
tinal inflammation and fibrosis whereas
inbred Buffalo and Fischer F344 (major
histocompatibility complex matched
with Lewis) rats develop only transient
intestinal inflammation and no sys-
temic manifestations (Table 2). Lewis
rats injected subserosally with the bac-
terial cell wall polymer peptidoglycan-
polysaccharide (PG-PS) develop
chronic, spontaneously relapsing,
granulomatous enterocolitis with fibro-
sis and associated polyarthritis, granu-
lomatous hepatitis, leukocytosis and
anemia which persists for at least 16
weeks (5,21). With identical exposure
to PG-PS, Buffalo or Fischer rats exhibit
only transient local inflammation,
which resolves by 14 days, with residual
damage and no chronic enterocolitis or
extraintestinal manifestations. Out-
bred Sprague-Dawley rats develop
chronic granulomatous enterocolitis,
but the chronic intestinal inflamma-
tion is less pronounced and there is no
extraintestinal disease (22).
In a second model, Lewis rats
injected subcutaneously with in-
domethacin (7.5 mg/kg/day for two
days) developed chronic mid-small
bowel longitudinal ulcers with fibrosis
and associated hepatobiliary inflamma-
tion, anemia and leukocytosis which
persisted for at least 77 days, whereas
Fischer rats had no residual inflamma-
tion 14 days after indomethacin (23).
Similarly, Lewis rats – but not Buffalo
or Fischer rats – developed chronic, fi-
brotic hepatobiliary inflammation in
response to experimental small intesti-
nal overgrowth of anaerobic bacteria
following surgical creation of jejunal
self-filling blind loops (24). In this
model, Lewis rats develop clinical (he-
patomegaly), biochemical (increased
plasma aspartate aminotransferase),
histological and cholangiographic evi-
TABLE 2
Differential susceptibility of inbred rats to experimental enterocolitis and sys-
temic inflammation
High responder Intermediate responders Low responders
Lewis Sprague-Dawley Fischer F344
Wistar Buffalo
TABLE 3
Differential host susceptibility of inbred mice to experimental colitis
Model High responders Low responders
Trinitrobenzene sulphonic acid/
ethanol
Balb/C, C3H/HeN DBA/2, C57/BL
Citrobacter freundii C3H/HeJ DBA/2J
T cell receptor alpha knockout C3H/He Balb/C, C57BL/6
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dence of hepatobiliary inflammation
two to four weeks after formation of the
self-filling blind loops. Wistar rats de-
velop similar lesions by eight and 12
weeks, but Fischer and Buffalo rats fail
to develop hepatobiliary injury despite
very similar luminal bacterial concen-
trations in all rat strains. Thus, with
identical stimuli, Lewis rats develop
chronic, spontaneously relapsing in-
flammation with extraintestinal in-
flammation, but Buffalo and Fischer
rats develop transient, self-limited in-
flammation with no local or systemic
complications.
Lewis rats are high responders in a
number of inflammatory models, in-
cluding autoimmune encephalitis, thy-
roiditis, uveitis and arthritis (adjuvant,
collagen and PG-PS-induced) (25,26).
Experimental data support two theories
to explain mechanisms of enhanced
susceptibility to inflammation in Lewis
rats: defective acute hypothalamic/
pituitary/adrenal responses to IL-1 and
PG-PS (27); and disordered regulation
of the immune response. In support of
the latter theory, Lewis rats have an in-
creased ratio of cecal IL-1:IL-1ra MRNA
during the chronic phase of PG-PS-i-
nduced inflammation relative to resis-
tant Buffalo and Fischer rats (21).
Moreover, noninflamed intestinal tis-
sues from Lewis, but not Fischer and
Buffalo, rats constitutively express
MRNA for tumour necrosis factor and
an IL-8-like molecule (28), suggesting
that the mucosal immune system of
the Lewis rat is in a ‘primed’ state. The
author has also demonstrated that T
lymphocytes regulate the chronic, re-
lapsing granulomatous phase of
PG-PS-induced enterocolitis and sys-
temic inflammation based on observa-
tions that Lewis athymic (nude) rats
fail to develop enterocolitis and arthri-
tis, and that cyclosporin A prevents
and treats chronic intestinal and sys-
temic inflammation (29). These results
complement the author’s observations
in IBD patients and observations by
Bristol et al (30) that PG-PS stimulated
peritoneal macrophages from Lewis
rats have an increased IL-1:IL-1ra ratio
relative to Buffalo rats. Patients with
active Crohn’s disease and ulcerative
colitis have significantly increased
tissue IL-1:IL-1ra and MRNA protein ra-
tios compared with controls (31,32).
Inbred mouse strains: Beagley and co-
workers (33) have reported that Balb/C
and C3H/HeN mice developed a
chronic colitis upon repeated weekly
administration of trinitrobenzene sul-
phonic acid/ethanol enemas, but
DBA/2 and C57/BL mice were resistant
to chronic inflammation (Table 3).
Similarly, C3H/HeJ mice developed
more extensive colonic inflammation
and ulcerations than DBA/2J mice fol-
lowing experimental infection with
Citrobacter freundii, although the two
strains developed similar degrees of
epithelial hyperplasia (34). However,
inbred mouse strain susceptibility is not
entirely consistent because Mombaerts
et al (15) found that TCR-alpha chain-
deficient mice on the 129/SV back-
ground and 129/SVxC3H/He crosses
develop severe intestinal inflammation
more rapidly (four to six months of age)
and with a higher incidence than those
129/SV mice crossed with C57BL/6 or
Balb/C strain, which develop a less se-
vere disease with a slower onset. The
only mouse strain that displayed consis-
tent high susceptibility in these models
was the C3H/He background (C3H/
HeN or C3H/JHeJ), which is the parent
strain for the C3H/HeJ Bir mice that
spontaneously develop colitis (9).
SUMMARY AND
CONCLUSIONS
The studies discussed above clearly
demonstrate that the chronicity, ag-
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Figure 1) The influence of genetic susceptibility on chronicity of inflammation is presented. Episodic enteric infections, environment toxins and enhanced
mucosal uptake of ubiquitous bacterial constituents induce transient injury in all hosts. The normal response is appropriate suppression of inflammation
with no residual damage (upper arm). However, genetically susceptible hosts amplify the inflammatory response, which leads to chronic tissue damage.
FMLP n-formyl-methionyl-leucyl phenylalanine; LPS Lipopolysaccharide, endotoxin; NSAIDs Nonsteroidal anti-inflammatory drugs; PG-PS Peptidoglycan-
polysaccharide. Reprinted with permission from: Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease, ulcerative colitis and experimental in-
testinal inflammation. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease, 4th edn. Baltimore: Williams & Wilkins, 1995:96-124
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gressiveness and complications of in-
duced intestinal inflammation depend
on host genetic susceptibility. Further-
more, spontaneous mutation or altered
expression of a single gene can induce
spontaneous colitis. Genetically en-
gineered models demonstrate that al-
teration of any of a number of key
immunoregulatory cytokine or T
lymphocyte gene products can lead to
phenotypically similar intestinal in-
flammatory conditions. Furthermore,
inbred rodent strains susceptible to in-
duced intestinal inflammation exhibit
immunoregulatory defects (Lewis rats
increased IL-1:IL-1ra ratio and C3H/HeJ
lipopolysaccharide-unresponsiveness).
These observations in animal models
suggest that human IBD can arise from a
number of mutations of immunoregula-
tory molecules, supporting the concept
of genetic heterogeneity for ulcerative
colitis and Crohn’s disease.
The author suggests that geneti-
cally determined defects in immu-
noregulation or perhaps mucosal
barrier integrity can alter the delicate
balance among phlogistic luminal bac-
terial constituents, dietary antigens
and mucosal protective forces, and pro-
poses that the genetic susceptibility of
high responding hosts (Lewis rats and
perhaps IBD patients) is due to an in-
ability to downregulate appropri-
ately the inflammatory response to
ubiquitous luminal antigens, probably
of bacterial origin (35). This theory
predicts that events initiating inflam-
mation may be nonspecific (self-
limited infection, nonsteroidal anti-
inflammatory drugs, toxins) and pro-
duce acute inflammation of similar
degree in all hosts (Figure 1). The nor-
mal, genetically resistant host appro-
priately downregulates inflammation,
which heals with no residual damage.
However, the genetically susceptible
host (Lewis rat, IBD patient), due to de-
fective immunosuppression, ampli-
fies the inflammatory response to
develop aggressive tissue injury, fibrosis
and extraintestinal inflammation. Bet-
ter understanding of genetically deter-
mined defects in immunoregulation of
the Lewis rat, and C3H/HeJ and
C3H/HeN mice, and identification of
the spontaneous genetic mutation(s) of
the C3H/HeJ Bir mouse should lead to
valuable insights into the genetic regu-
lation of experimental chronic intesti-
nal and extraintestinal inflammation
that can be rapidly tested in IBD pa-
tients.
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